OBJECTIVE: To identify the cause of disease in an adult patient presenting with recent-onset fevers, chills, urticaria, fatigue, and profound myalgia, who was found to be negative for cryopyrin-associated periodic syndrome (CAPS) NLRP3 mutations by conventional Sanger DNA sequencing. METHODS: We performed whole-exome sequencing and targeted deep sequencing using DNA from the patient's whole blood to identify a possible NLRP3 somatic mutation. We then screened for this mutation in subcloned NLRP3 amplicons from fibroblasts, buccal cells, granulocytes, negatively selected monocytes, and T and B lymphocytes and further confirmed the somatic mutation by targeted sequencing of exon 3. RESULTS: We identified a previously reported CAPS-associated mutation, p.Tyr570Cys, with a mutant allele frequency of 15% based on exome data. Targeted sequencing and subcloning of NLRP3 amplicons confirmed the presence of the somatic mutation in whole blood at a ratio similar to the exome data. The mutant allele frequency was in the range of 13.3-16.8% in monocytes and 15.2-18% in granulocytes. Notably, this mutation was either absent or present at a very low frequency in B and T lymphocytes, in buccal cells, and in the patient's cultured fibroblasts. CONCLUSION: Our findings indicate the possibility of myeloid-restricted somatic mosaicism in the pathogenesis of CAPS, underscoring the emerging role of massively parallel sequencing in clinical diagnosis. Published 2015. This article is a U.S. Government work and is in the public domain in the USA.
OBJECTIVE: To identify the cause of disease in an adult patient presenting with recent-onset fevers, chills, urticaria, fatigue, and profound myalgia, who was found to be negative for cryopyrin-associated periodic syndrome (CAPS) NLRP3 mutations by conventional Sanger DNA sequencing. METHODS: We performed whole-exome sequencing and targeted deep sequencing using DNA from the patient's whole blood to identify a possible NLRP3 somatic mutation. We then screened for this mutation in subcloned NLRP3 amplicons from fibroblasts, buccal cells, granulocytes, negatively selected monocytes, and T and B lymphocytes and further confirmed the somatic mutation by targeted sequencing of exon 3. RESULTS: We identified a previously reported CAPS-associated mutation, p.Tyr570Cys, with a mutant allele frequency of 15% based on exome data. Targeted sequencing and subcloning of NLRP3 amplicons confirmed the presence of the somatic mutation in whole blood at a ratio similar to the exome data. The mutant allele frequency was in the range of 13.3-16.8% in monocytes and 15.2-18% in granulocytes. Notably, this mutation was either absent or present at a very low frequency in B and T lymphocytes, in buccal cells, and in the patient's cultured fibroblasts. CONCLUSION: Our findings indicate the possibility of myeloid-restricted somatic mosaicism in the pathogenesis of CAPS, underscoring the emerging role of massively parallel sequencing in clinical diagnosis. Published 2015. This article is a U.S. Government work and is in the public domain in the USA.
Authors: Ivona Aksentijevich; Miroslawa Nowak; Mustapha Mallah; Jae Jin Chae; Wendy T Watford; Sigrun R Hofmann; Leonard Stein; Ricardo Russo; Donald Goldsmith; Peter Dent; Helene F Rosenberg; Frances Austin; Elaine F Remmers; James E Balow; Sergio Rosenzweig; Hirsh Komarow; Nitza G Shoham; Geryl Wood; Janet Jones; Nadira Mangra; Hector Carrero; Barbara S Adams; Terry L Moore; Kenneth Schikler; Hal Hoffman; Daniel J Lovell; Robert Lipnick; Karyl Barron; John J O'Shea; Daniel L Kastner; Raphaela Goldbach-Mansky Journal: Arthritis Rheum Date: 2002-12
Authors: Juan I Aróstegui; Ma Dolores Lopez Saldaña; Mariona Pascal; Daniel Clemente; Marta Aymerich; Francesc Balaguer; Ajay Goel; Concepción Fournier del Castillo; Josefa Rius; Susana Plaza; Juan Carlos López Robledillo; Manel Juan; Mercedes Ibañez; Jordi Yagüe Journal: Arthritis Rheum Date: 2010-04
Authors: Ebun Omoyinmi; Sónia Melo Gomes; Ariane Standing; Dorota M Rowczenio; Despina Eleftheriou; Nigel Klein; Juan I Aróstegui; Helen J Lachmann; Philip N Hawkins; Paul A Brogan Journal: Arthritis Rheumatol Date: 2014-01 Impact factor: 10.995
Authors: Dorota M Rowczenio; Shelly Pathak; Juan I Arostegui; Anna Mensa-Vilaro; Ebun Omoyinmi; Paul Brogan; Dan Lipsker; Thomas Scambler; Roger Owen; Hadija Trojer; Anna Baginska; Julian D Gillmore; Ashutosh D Wechalekar; Thirusha Lane; Rene Williams; Taryn Youngstein; Philip N Hawkins; Sinisa Savic; Helen J Lachmann Journal: Blood Date: 2017-12-28 Impact factor: 22.113
Authors: Stephanie R Harrison; Dennis McGonagle; Sharmin Nizam; Stephen Jarrett; Jeroen van der Hilst; Michael F McDermott; Sinisa Savic Journal: JCI Insight Date: 2016-05-05